The genetics of the opioid system and specific drug addictions

Human Genetics

Volumn 131, Issue 6, 2012, Pages 823-842

  Levran, Orna ^a   Yuferov, Vadim ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALCOHOL; BUPRENORPHINE; CANNABIS; COCAINE; CORTICOTROPIN RELEASING FACTOR; DELTA OPIATE RECEPTOR; DIAMORPHINE; ENKEPHALIN; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; KAPPA OPIATE RECEPTOR; METHADONE; METHAMPHETAMINE; METYRAPONE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALMEFENE; NALTREXONE; NEUROSTEROID; NOCICEPTIN; OPIATE; OPIATE RECEPTOR; PHENYLALANINE; PRODYNORPHIN; PROENKEPHALIN; PROOPIOMELANOCORTIN; STAT6 PROTEIN; VALINE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADOLESCENCE; ADRENAL CORTEX; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOLISM; ANXIETY; BINDING AFFINITY; BINDING SITE; BRAIN TISSUE; CANNABIS ADDICTION; CHROMOSOME 1P; CHROMOSOME 8; CLINICAL EFFECTIVENESS; COCAINE DEPENDENCE; DRINKING BEHAVIOR; DRUG DEPENDENCE; EUPHORIA; EXON; EXPLORATORY BEHAVIOR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; HAPLOTYPE; HEREDITY; HEROIN DEPENDENCE; HORMONE INHIBITION; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; INTRON; MATERNAL DEPRIVATION; META ANALYSIS (TOPIC); METHAMPHETAMINE DEPENDENCE; METHYLATION; NONHUMAN; OPIATE ADDICTION; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PSYCHOSIS; RECEPTOR BINDING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; SUBSTANCE ABUSE; TREATMENT RESPONSE;

GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NARCOTIC ANTAGONISTS; PHENOTYPE; RECEPTORS, OPIOID; SUBSTANCE-RELATED DISORDERS;

EID: 84862667520     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-012-1172-4     Document Type: Review

References (168)

1. RF Anton G Oroszi S O'Malley D Couper R Swift H Pettinati D Goldman 2008 An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study Arch Gen Psychiatry 65 135 144 18250251 1:CAS:528:DC%2BD1cXivVOms7Y%3D 10.1001/archpsyc.65.2.135
2. A Arias R Feinn HR Kranzler 2006 Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis Drug Alcohol Depend 83 262 268 16387451 1:CAS:528: DC%2BD28Xmt1Oqsrk%3D 10.1016/j.drugalcdep.2005.11.024
3. AJ Arias S Armeli J Gelernter J Covault A Kallio S Karhuvaara T Koivisto R Makela HR Kranzler 2008 Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers Alcohol Clin Exp Res 32 1159 1166 18537939 1:CAS:528:DC%2BD1cXpvFGntL0%3D 10.1111/j.1530-0277.2008.00735.x
4. CC Babbitt JS Silverman R Haygood JM Reininga MV Rockman GA Wray 2010 Multiple functional variants in cis modulate PDYN expression Mol Biol Evol 27 465 479 19910384 1:CAS:528:DC%2BC3cXntlGmsA%3D%3D 10.1093/molbev/msp276
5. CS Barr M Schwandt SG Lindell SA Chen D Goldman SJ Suomi JD Higley M Heilig 2007 Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques Arch Gen Psychiatry 64 369 376 17339526 1:CAS:528:DC%2BD2sXjs1yntb4%3D 10.1001/archpsyc.64.3.369
6. CS Barr SA Chen ML Schwandt SG Lindell H Sun SJ Suomi M Heilig 2010 Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus Biol Psychiatry 67 78 80 19748082 1:CAS:528:DC%2BD1MXhsFGrsbnJ 10.1016/j.biopsych. 2009.07.026
7. G Bart M Heilig KS LaForge L Pollak SM Leal J Ott MJ Kreek 2004 Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden Mol Psychiatry 9 547 549 15037869 1:CAS:528:DC%2BD2cXkt1Gnt7k%3D 10.1038/sj.mp.4001504
8. G Bart MJ Kreek J Ott KS LaForge D Proudnikov L Pollak M Heilig 2005 Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden Neuropsychopharmacology 30 417 422 15525999 1:CAS:528:DC%2BD2MXksVOhtg%3D%3D 10.1038/sj.npp.1300598
9. G Bart KS LaForge L Borg C Lilly A Ho MJ Kreek 2006 Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the mu opioid receptor gene Neuropsychopharmacology 31 2313 2317 16794569 1:CAS:528:DC%2BD28Xps1Whsbs%3D
10. B Bayerer U Stamer A Hoeft F Stuber 2007 Genomic variations and transcriptional regulation of the human mu-opioid receptor gene Eur J Pain 11 421 427 16843022 1:CAS:528:DC%2BD2sXivVSit7g%3D 10.1016/j.ejpain.2006.06.004
11. D Bebawy P Marquez S Samboul D Parikh A Hamid K Lutfy 2010 Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice Biol Psychiatry 68 223 230 20359694 1:CAS:528:DC%2BC3cXovFCisbg%3D 10.1016/j.biopsych.2010.02.010
12. K Befort D Filliol FM Decaillot C Gaveriaux-Ruff MR Hoehe BL Kieffer 2001 A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling J Biol Chem 276 3130 3137 11067846 1:CAS:528:DC%2BD3MXhtFWjtb0%3D 10.1074/jbc.M006352200
13. AW Bergen J Kokoszka R Peterson JC Long M Virkkunen M Linnoila D Goldman 1997 Mu opioid receptor gene variants: lack of association with alcohol dependence Mol Psychiatry 2 490 494 9399694 1:STN:280:DyaK1c%2FmtVKitw%3D%3D 10.1038/sj.mp.4000331
14. A Beyer T Koch H Schroder S Schulz V Hollt 2004 Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor J Neurochem 89 553 560 15086512 1:CAS:528:DC%2BD2cXjslWqurg%3D 10.1111/j.1471-4159.2004. 02340.x
15. C Bond KS LaForge M Tian D Melia S Zhang L Borg J Gong J Schluger JA Strong SM Leal JA Tischfield MJ Kreek L Yu 1998 Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction Proc Natl Acad Sci USA 95 9608 9613 9689128 1:CAS:528:DyaK1cXltlClsbY%3D 10.1073/pnas.95.16.9608
16. CA Bousman SJ Glatt IP Everall MT Tsuang 2009 Genetic association studies of methamphetamine use disorders: a systematic review and synthesis Am J Med Genet B Neuropsychiatr Genet 150B 1025 1049 19219857 1:CAS:528: DC%2BC3cXitlClsA%3D%3D 10.1002/ajmg.b.30936
17. Bousman CA, Glatt SJ, Cherner M, Atkinson JH, Grant I, Tsuang MT, Everall IP (2010) Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res 178:295-298
18. JA Briant DA Nielsen D Proudnikov D Londono A Ho J Ott MJ Kreek 2010 Evidence for association of two variants of the nociceptin/orphanin FQ receptor gene OPRL1 with vulnerability to develop opiate addiction in Caucasians Psychiatr Genet 20 65 72 20032820 10.1097/YPG.0b013e32833511f6
19. MR Bruchas BB Land C Chavkin 2010 The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors Brain Res 1314 44 55 19716811 1:CAS:528:DC%2BC3cXhtlelsL8%3D 10.1016/j.brainres.2009.08.062
20. LL Cavalli-Sforza MW Feldman 2003 The application of molecular genetic approaches to the study of human evolution Nat Genet 33 Suppl 266 275 12610536 1:CAS:528:DC%2BD3sXhsV2ktL0%3D 10.1038/ng1113
21. VI Chefer T Czyzyk EA Bolan J Moron JE Pintar TS Shippenberg 2005 Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine J Neurosci 25 5029 5037 15901784 1:CAS:528:DC%2BD2MXkslegsro%3D 10.1523/JNEUROSCI.0854-05.2005
22. AC Chen KS LaForge A Ho PF McHugh S Kellogg K Bell RP Schluger SM Leal MJ Kreek 2002 Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse Am J Med Genet 114 429 435 11992566 10.1002/ajmg.10362
23. HS Choi CS Kim CK Hwang KY Song W Wang Y Qiu PY Law LN Wei HH Loh 2006 The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor Biochem Biophys Res Commun 343 1132 1140 16580639 1:CAS:528:DC%2BD28XksFaiu7Y%3D 10.1016/j.bbrc.2006.03.084
24. RY Chong L Oswald X Yang M Uhart PI Lin GS Wand 2006 The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress Neuropsychopharmacology 31 204 211 16123758 1:CAS:528:DC%2BD2MXhtlWjsr3F
25. TK Clarke K Krause T Li G Schumann 2009 An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population Addict Biol 14 366 370 19298317 1:CAS:528:DC%2BD1MXovFSgtb0%3D 10.1111/j.1369-1600. 2009.00151.x
26. DE Comings H Blake G Dietz R Gade-Andavolu RS Legro G Saucier P Johnson R Verde JP MacMurray 1999 The proenkephalin gene (PENK) and opioid dependence NeuroReport 10 1133 1135 10321497 1:CAS:528:DyaK1MXkt1Cht7c%3D 10.1097/00001756-199904060-00042
27. S Crettol J Besson M Croquette-Krokar R Hammig I Gothuey M Monnat JJ Deglon M Preisig CB Eap 2008 Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment Prog Neuropsychopharmacol Biol Psychiatry 32 1722 1727 18687376 1:CAS:528: DC%2BD1cXhtFartLbN 10.1016/j.pnpbp.2008.07.009
28. JJ Crowley DW Oslin AA Patkar E Gottheil PA DeMaria Jr. CP O'Brien WH Berrettini DE Grice 2003 A genetic association study of the mu opioid receptor and severe opioid dependence Psychiatr Genet 13 169 173 12960749 10.1097/00041444-200309000-00006
29. P Cruz-Gordillo O Fedrigo GA Wray CC Babbitt 2010 Extensive changes in the expression of the opioid genes between humans and chimpanzees Brain Behav Evol 76 154 162 21079395 10.1159/000320968
30. Crystal HA, Hamon S, Randesi M, Cook J, Anastos K, Lazar J, Liu C, Pearce L, Golub E, Valcour V, Weber KM, Holman S, Ho A, Kreek MJ (2012) A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women. Addict Biol 17:181-191
31. JA Culpepper-Morgan MJ Kreek 1997 Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone-induced withdrawal Metabolism 46 130 134 9030816 1:CAS:528:DyaK2sXht1emsbg%3D 10.1016/S0026-0495(97)90289-4
32. JP Dahl AE Weller KM Kampman DW Oslin FW Lohoff TN Ferraro CP O'Brien WH Berrettini 2005 Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence Am J Med Genet B Neuropsychiatr Genet 139B 106 108 16184603 10.1002/ajmg.b.30238
33. I Deb J Chakraborty PK Gangopadhyay SR Choudhury S Das 2010 Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction J Neurochem 112 486 496 19891732 1:CAS:528: DC%2BC3cXhtVGisrw%3D 10.1111/j.1471-4159.2009.06472.x
34. AM Dlugos A Hamidovic C Hodgkinson PH Shen D Goldman AA Palmer H de Wit 2011 OPRM1 gene variants modulate amphetamine-induced euphoria in humans Genes Brain Behav 10 199 209 21029375 1:CAS:528:DC%2BC3MXks1Kgt7s%3D 10.1111/j.1601-183X.2010.00655.x
35. RM Dores AJ Baron 2011 Evolution of POMC: origin, phylogeny, posttranslational processing, and the melanocortins Ann N Y Acad Sci 1220 34 48 21388402 1:CAS:528:DC%2BC3MXkvVyrtrg%3D 10.1111/j.1749-6632.2010.05928.x
36. K Drakenberg A Nikoshkov MC Horvath P Fagergren A Gharibyan K Saarelainen S Rahman I Nylander G Bakalkin J Rajs E Keller YL Hurd 2006 Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers Proc Natl Acad Sci USA 103 7883 7888 16682632 1:CAS:528:DC%2BD28XlsVGksbw%3D 10.1073/pnas.0600871103
37. Ducat E, Ray B, Bart G, Umemura Y, Varon J, Ho A, Kreek MJ (2011) Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone. Addict Biol (in press)
38. HJ Edenberg J Wang H Tian S Pochareddy X Xuei L Wetherill A Goate T Hinrichs S Kuperman JI Nurnberger Jr. M Schuckit JA Tischfield T Foroud 2008 A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence Hum Mol Genet 17 1783 1789 18319328 1:CAS:528:DC%2BD1cXmsFKisro%3D 10.1093/hmg/ddn068
39. CL Ehlers PA Lind KC Wilhelmsen 2008 Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians BMC Med Genet 9 35 18433502 10.1186/1471-2350-9-35 1:CAS:528:DC%2BD1cXnvFKnu78%3D
40. W el Loh CS Fann YT Chang CJ Chang AT Cheng 2004 Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han Alcohol Clin Exp Res 28 15 19 10.1097/01.ALC.0000106303.41755.B8
41. FM Filbey L Ray A Smolen ED Claus A Audette KE Hutchison 2008 Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes Alcohol Clin Exp Res 32 1113 1123 18540916 10.1111/j.1530-0277.2008.00692.x
42. P Franke MM Nothen T Wang H Neidt M Knapp D Lichtermann O Weiffenbach P Mayer V Hollt P Propping W Maier 1999 Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence Am J Med Genet 88 462 464 10490698 1:STN:280:DyaK1MvitFCrtg%3D%3D 10.1002/(SICI)1096-8628(19991015)88: 5<462::AID-AJMG4>3.0.CO;2-S
43. P Franke T Wang MM Nothen M Knapp H Neidt S Albrecht E Jahnes P Propping W Maier 2001 Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence Am J Med Genet 105 114 119 11424981 1:STN:280:DC%2BD3Mzmtlehsg%3D%3D 10.1002/1096-8628(20010108)105: 1<114::AID-AJMG1074>3.0.CO;2-L
44. EC Gavioli A Rizzi G Marzola S Zucchini D Regoli G Calo 2007 Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice Peptides 28 1229 1239 17499882 1:CAS:528:DC%2BD2sXmtVaiu70%3D 10.1016/j.peptides.2007.04.012
45. T Geijer E Jonsson J Neiman A Gyllander G Sedvall U Rydberg L Terenius 1997 Prodynorphin allelic distribution in Scandinavian chronic alcoholics Alcohol Clin Exp Res 21 1333 1336 9347097 1:CAS:528:DyaK2sXnt1OrtL8%3D 10.1111/j.1530-0277.1997.tb04456.x
46. J Gelernter H Kranzler J Cubells 1999 Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects Mol Psychiatry 4 476 483 10523821 1:CAS:528:DC%2BD3cXlvVWlur0%3D 10.1038/sj.mp.4000556
47. J Gelernter R Gueorguieva HR Kranzler H Zhang J Cramer R Rosenheck JH Krystal 2007 Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study Alcohol Clin Exp Res 31 555 563 17374034 1:CAS:528: DC%2BD2sXks1Gksbk%3D
48. G Gerra C Leonardi E Cortese A D'Amore A Lucchini G Strepparola G Serio G Farina F Magnelli A Zaimovic A Mancini M Turci M Manfredini C Donnini 2007 Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction Am J Med Genet B Neuropsychiatr Genet 144 771 775
49. A Gieryk B Ziolkowska W Solecki J Kubik R Przewlocki 2010 Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity Psychopharmacology 208 291 300 19997907 1:CAS:528:DC%2BD1MXhsFaqtLrF 10.1007/s00213-009-1730-1
50. SJ Glatt C Bousman RS Wang KK Murthy BK Rana JA Lasky-Su SC Zhu R Zhang J Li B Zhang J Li MJ Lyons SV Faraone MT Tsuang 2007 Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis Drug Alcohol Depend 90 159 165 17416470 1:CAS:528:DC%2BD2sXpsFGkt7g%3D 10.1016/j.drugalcdep.2007.02.022
51. N Gscheidel T Sander B Wendel P Heere LG Schmidt H Rommelspacher MR Hoehe J Samochowiec 2000 Five exon 1 variants of mu opioid receptor and vulnerability to alcohol dependence Pol J Pharmacol 52 27 31 10949117 1:CAS:528: DC%2BD3cXisFOgs7c%3D
52. CA Hernandez-Avila G Wand X Luo J Gelernter HR Kranzler 2003 Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1) Am J Med Genet B Neuropsychiatr Genet 118 60 65 10.1002/ajmg.b.10054
53. CA Hernandez-Avila J Covault G Wand H Zhang J Gelernter HR Kranzler 2007 Population-specific effects of the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1) on HPA-axis activation Pharmacogenet Genomics 17 1031 1038 18004207 1:CAS:528:DC%2BD2sXhsVWiu7%2FP 10.1097/FPC.0b013e3282f0b99c
54. CA Hodgkinson Q Yuan K Xu PH Shen E Heinz EA Lobos EB Binder J Cubells CL Ehlers J Gelernter J Mann B Riley A Roy B Tabakoff RD Todd Z Zhou D Goldman 2008 Addictions biology: haplotype-based analysis for 130 candidate genes on a single array Alcohol Alcohol 43 505 515 18477577 1:CAS:528:DC%2BD1cXhtF2rtbjE
55. MR Hoehe K Kopke B Wendel K Rohde C Flachmeier KK Kidd WH Berrettini GM Church 2000 Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence Hum Mol Genet 9 2895 2908 11092766 1:CAS:528:DC%2BD3cXoslWmsLc%3D 10.1093/hmg/9.19.2895
56. J Huang B Young MT Pletcher M Heilig C Wahlestedt 2008 Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence Addict Biol 13 88 94 18269382 1:CAS:528:DC%2BD1cXktVaitrw%3D 10.1111/j.1369-1600.2007.00089.x
57. S Ide H Kobayashi K Tanaka H Ujike Y Sekine N Ozaki T Inada M Harano T Komiyama M Yamada M Iyo K Ikeda I Sora 2004 Gene polymorphisms of the mu opioid receptor in methamphetamine abusers Ann N Y Acad Sci 1025 316 324 15542732 1:CAS:528:DC%2BD2MXltVSiug%3D%3D 10.1196/annals.1316.039
58. S Ide H Kobayashi H Ujike N Ozaki Y Sekine T Inada M Harano T Komiyama M Yamada M Iyo N Iwata K Tanaka H Shen K Iwahashi M Itokawa M Minami M Satoh K Ikeda I Sora 2006 Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms Pharmacogenomics J 6 179 188 16402083 1:CAS:528:DC%2BD28XkvVSktrY%3D 10.1038/sj.tpj.6500355
59. E Ito G Xie K Maruyama PP Palmer 2000 A core-promoter region functions bi-directionally for human opioid-receptor-like gene ORL1 and its 5â€-adjacent gene GAIP J Mol Biol 304 259 270 11090272 1CAS:528:DC%2BD3cXot1Klt7c%3D 10.1006/jmbi.2000.4212
60. N Jayaram-Lindstrom A Hammarberg O Beck J Franck 2008 Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial Am J Psychiatry 165 1442 1448 18765480 10.1176/appi.ajp.2008.08020304
61. N Jayaram-Lindstrom M Konstenius S Eksborg O Beck A Hammarberg J Franck 2008 Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence Neuropsychopharmacology 33 1856 1863 17957221 10.1038/sj.npp.1301572 1:CAS:528:DC%2BD1cXntFShsrY%3D
62. J Kakko J von Wachenfeldt KD Svanborg J Lidstrom CS Barr M Heilig 2008 Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence Biol Psychiatry 63 172 177 17850768 1:CAS:528:DC%2BD1cXhsFShtA%3D%3D 10.1016/j.biopsych.2007.05.001
63. S Kapur S Sharad RA Singh AK Gupta 2007 A118G polymorphism in mu opioid receptor gene (OPRM1): association with opiate addiction in subjects of Indian origin J Integr Neurosci 6 511 522 18181266 10.1142/S0219635207001635
64. SH Kellogg PF McHugh K Bell JH Schluger RP Schluger KS LaForge A Ho MJ Kreek 2003 The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications Drug Alcohol Depend 69 137 150 12609695 10.1016/S0376-8716(02)00308-3
65. F Kiefer H Jahn M Schick K Wiedemann 2002 Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship Psychopharmacology 164 239 240 12404089 1:CAS:528:DC%2BD38Xot1Ciu7s%3D 10.1007/s00213-002-1255-3
66. SG Kim CM Kim DH Kang YJ Kim WT Byun SY Kim JM Park MJ Kim DW Oslin 2004 Association of functional opioid receptor genotypes with alcohol dependence in Koreans Alcohol Clin Exp Res 28 986 990 15252283 1:CAS:528:DC%2BD2cXls1agsLg%3D 10.1097/01.ALC.0000130803.62768.AB
67. AC King J Schluger M Gunduz L Borg G Perret A Ho MJ Kreek 2002 Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism Neuropsychopharmacology 26 778 788 12007748 1:CAS:528: DC%2BD38Xjtl2nt7o%3D 10.1016/S0893-133X(01)00416-X
68. AT Knoll WA Carlezon Jr. 2010 Dynorphin, stress, and depression Brain Res 1314 56 73 19782055 1:CAS:528:DC%2BC3cXhtlelsLw%3D 10.1016/j.brainres.2009.09. 074
69. H Kobayashi H Hata H Ujike M Harano T Inada T Komiyama M Yamada Y Sekine N Iwata M Iyo N Ozaki M Itokawa M Naka S Ide K Ikeda Y Numachi I Sora 2006 Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence/psychosis Am J Med Genet B Neuropsychiatr Genet 141B 482 486 16741914 1:CAS:528:DC%2BD2sXmsFalsLc%3D 10.1002/ajmg.b.30337
70. T Koch T Kroslak M Averbeck P Mayer H Schroder E Raulf V Hollt 2000 Allelic variation S268P of the human mu-opioid receptor affects both desensitization and G protein coupling Mol Pharmacol 58 328 334 10908300 1:CAS:528:DC%2BD3cXlsVymsL0%3D
71. G Koob MJ Kreek 2007 Stress, dysregulation of drug reward pathways, and the transition to drug dependence Am J Psychiatry 164 1149 1159 17671276 10.1176/appi.ajp.2007.05030503
72. HR Kranzler J Gelernter S O'Malley CA Hernandez-Avila D Kaufman 1998 Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1) Alcohol Clin Exp Res 22 1359 1362 9756053 1:CAS:528:DyaK1cXmtlOmtrw%3D
73. J Kraus C Borner E Giannini K Hickfang H Braun P Mayer MR Hoehe A Ambrosch W Konig V Hollt 2001 Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site J Biol Chem 276 43901 43908 11572871 1:CAS:528:DC%2BD3MXos12ntLo%3D 10.1074/jbc.M107543200
74. J Kraus C Borner E Giannini V Hollt 2003 The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene Mol Pharmacol 64 876 884 14500744 1:CAS:528:DC%2BD3sXnslGrurk%3D 10.1124/mol.64.4.876
75. MJ Kreek 1973 Medical safety and side effects of methadone in tolerant individuals JAMA 223 665 668 4739193 1:STN:280:DyaE3s%2Fns1Grtw%3D%3D 10.1001/jama.1973.03220060039009
76. MJ Kreek GF Koob 1998 Drug dependence: stress and dysregulation of brain reward pathways Drug Alcohol Depend 51 23 47 1:CAS:528:DyaK1cXks1OlsLg%3D 10.1016/S0376-8716(98)00064-7 9716928
77. MJ Kreek SL Wardlaw N Hartman J Raghunath J Friedman B Schneider AG Frantz 1983 Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans Life Sci 33 Suppl 1 409 411 6319894 1:CAS:528:DyaL3sXmtVKltb4%3D 10.1016/0024-3205(83)90529-5
78. MJ Kreek KS LaForge E Butelman 2002 Pharmacotherapy of addictions Nat Rev Drug Discov 1 710 726 1:CAS:528:DC%2BD38XmslamtL4%3D 10.1038/nrd897 12209151
79. MJ Kreek G Bart C Lilly KS LaForge DA Nielsen 2005 Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments Pharmacol Rev 57 1 26 15734726 1:CAS:528:DC%2BD2MXis1Gmtrw%3D 10.1124/pr.57.1.1
80. MJ Kreek Y Zhou ER Butelman O Levran 2009 Opiate and cocaine addiction: from bench to clinic and back to the bench Curr Opin Pharmacol 9 74 80 19155191 1:CAS:528:DC%2BD1MXhsFKks70%3D 10.1016/j.coph.2008.12.016
81. T Kroslak KS LaForge RJ Gianotti A Ho DA Nielsen MJ Kreek 2007 The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor J Neurochem 103 77 87 1:CAS:528:DC%2BD2sXhtF2qu7nJ 17877633
82. A Kuzmin I Bazov D Sheedy T Garrick C Harper G Bakalkin 2009 Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics Brain Res 1305 Suppl S80 S85 19501074 1:CAS:528:DC%2BD1MXhsV2murzM 10.1016/j.brainres.2009.05.067
83. KS LaForge V Yuferov MJ Kreek 2000 Opioid receptor and peptide gene polymorphisms: potential implications for addictions Eur J Pharmacol 410 249 268 11134674 1:CAS:528:DC%2BD3cXovFKjurY%3D 10.1016/S0014-2999(00)00819-0
84. J Le Merrer A Plaza-Zabala C Del Boca A Matifas R Maldonado BL Kieffer 2011 Deletion of the delta opioid receptor gene impairs place conditioning but preserves morphine reinforcement Biol Psychiatry 69 700 703 21168121 10.1016/j.biopsych.2010.10.021 1:CAS:528:DC%2BC3MXjtV2qtrs%3D
85. TT Leskela PM Markkanen IA Alahuhta JT Tuusa UE Petaja-Repo 2009 Phe27Cys polymorphism alters the maturation and subcellular localization of the human delta opioid receptor Traffic 10 116 129 19000170 1:CAS:528: DC%2BD1MXnsF2qtQ%3D%3D 10.1111/j.1600-0854.2008.00846.x
86. O Levran D Londono K O'Hara DA Nielsen E Peles J Rotrosen P Casadonte S Linzy M Randesi J Ott M Adelson MJ Kreek 2008 Genetic susceptibility to heroin addiction: a candidate gene association study Genes Brain Behav 7 720 729 18518925 1:CAS:528:DC%2BD1cXhtlKru7bK 10.1111/j.1601-183X.2008.00410.x
87. O Levran D Londono K O'Hara M Randesi J Rotrosen P Casadonte S Linzy J Ott M Adelson MJ Kreek 2009 Heroin addiction in African Americans: a hypothesis-driven association study Genes Brain Behav 8 531 540 19500151 1:CAS:528:DC%2BD1MXpvVyrsLw%3D 10.1111/j.1601-183X.2009.00501.x
88. O Levran O Awolesi S Linzy M Adelson MJ Kreek 2011 Haplotype block structure of the genomic region of the mu opioid receptor gene J Hum Genet 56 147 155 21160491 1:CAS:528:DC%2BC3MXisVOjt7g%3D 10.1038/jhg.2010.150
89. X Li DE Keith Jr. CJ Evans 1996 Mu opioid receptor-like sequences are present throughout vertebrate evolution J Mol Evol 43 179 184 8703083 1:CAS:528:DyaK28XlvVahtr8%3D 10.1007/BF02338825
90. X Luo HR Kranzler H Zhao J Gelernter 2003 Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans Am J Med Genet B Neuropsychiatr Genet 120 97 108 10.1002/ajmg.b.20034
91. SD Mague JA Blendy 2010 OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models Drug Alcohol Depend 108 172 182 20074870 1:CAS:528:DC%2BC3cXlsFSns7c%3D 10.1016/j.drugalcdep.2009.12.016
92. SD Mague C Isiegas P Huang LY Liu-Chen C Lerman JA Blendy 2009 Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior Proc Natl Acad Sci USA 106 10847 10852 19528658 1:CAS:528: DC%2BD1MXnt1Ciurw%3D 10.1073/pnas.0901800106
93. BS Maher VI Vladimirov SJ Latendresse DL Thiselton R McNamee M Kang TB Bigdeli X Chen BP Riley JM Hettema H Chilcoat C Heidbreder P Muglia EL Murrelle DM Dick F Aliev A Agrawal HJ Edenberg J Kramer J Nurnberger JA Tischfield B Devlin RE Ferrell GP Kirillova RE Tarter KS Kendler MM Vanyukov 2011 The AVPR1A gene and substance use disorders: association, replication, and functional evidence Biol Psychiatry 70 519 527 21514569 1:CAS:528:DC%2BC3MXhtVOjsrnJ 10.1016/j.biopsych.2011.02.023
94. 2+ channels by heterologously expressed wild-type and mutant human mu-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism J Neurophysiol 97 1058 1067 17151221 1:CAS:528:DC%2BD2sXjs12hsbc%3D 10.1152/jn.01007.2006
95. P Mayer H Rochlitz E Rauch H Rommelspacher HE Hasse S Schmidt V Hollt 1997 Association between a delta opioid receptor gene polymorphism and heroin dependence in man NeuroReport 8 2547 2550 9261824 1:CAS:528:DyaK2sXls1Wntbs%3D 10.1097/00001756-199707280-00025
96. JE McGeary PM Monti DJ Rohsenow J Tidey R Swift R Miranda Jr. 2006 Genetic moderators of naltrexone's effects on alcohol cue reactivity Alcohol Clin Exp Res 30 1288 1296 16899031 1:CAS:528:DC%2BD28XovFylt7c%3D 10.1111/j.1530-0277.2006.00156.x
97. GM Miller J Bendor S Tiefenbacher H Yang MA Novak BK Madras 2004 A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression Mol Psychiatry 9 99 108 14699447 1:CAS:528:DC%2BD3sXhtVWhtr7M 10.1038/sj.mp.4001378
98. R Miranda L Ray A Justus LA Meyerson VS Knopik J McGeary PM Monti 2010 Initial evidence of an association between OPRM1 and adolescent alcohol misuse Alcohol Clin Exp Res 34 112 122 19860800 1:CAS:528:DC%2BC3cXhsVyrtL8%3D 10.1111/j.1530-0277.2009.01073.x
99. NP Murphy 2010 The nociceptin/orphanin FQ system as a target for treating alcoholism CNS Neurol Disord: Drug Targets 9 87 93 1:CAS:528: DC%2BC3cXjtFajsL4%3D
100. DA Nielsen F Ji V Yuferov A Ho A Chen O Levran J Ott MJ Kreek 2008 Genotype patterns that contribute to increased risk for or protection from developing heroin addiction Mol Psychiatry 13 417 428 18195715 1:CAS:528:DC%2BD1cXjtlykurc%3D 10.1038/sj.mp.4002147
101. A Nikoshkov YL Hurd T Yakovleva I Bazov Z Marinova G Cebers N Pasikova A Gharibyan L Terenius G Bakalkin 2005 Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain FASEB J 19 1543 1545 16014400 1:CAS:528:DC%2BD2MXpvF2gtrs%3D
102. A Nikoshkov K Drakenberg X Wang MC Horvath E Keller YL Hurd 2008 Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression Proc Natl Acad Sci USA 105 786 791 18184800 1:CAS:528:DC%2BD1cXhtVSjsr8%3D 10.1073/pnas.0710902105
103. D Nishizawa W Han J Hasegawa T Ishida Y Numata T Sato A Kawai K Ikeda 2006 Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population Neuropsychobiology 53 137 141 16679777 1:CAS:528:DC%2BD28Xlt1Sjurg%3D 10.1159/000093099
104. A Nomura H Ujike Y Tanaka K Otani Y Morita M Kishimoto A Morio M Harano T Inada M Yamada T Komiyama Y Sekine N Iwata I Sora M Iyo N Ozaki S Kuroda 2006 Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence Neurosci Lett 400 158 162 16529859 1:CAS:528:DC%2BD28XktVent7g%3D 10.1016/j.neulet.2006.02.038
105. CP O'Brien DR Gastfriend RF Forman E Schweizer HM Pettinati 2011 Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone Am J Addict 20 106 112 21314752
106. SS O'Malley S Krishnan-Sarin C Farren R Sinha MJ Kreek 2002 Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis Psychopharmacology 160 19 29 11862370 10.1007/s002130100919 1:CAS:528:DC%2BD38XisVKlu7w%3D
107. T Ono T Kaneda A Muto T Yoshida 2009 Positive transcriptional regulation of the human mu opioid receptor gene by poly(ADP-ribose) polymerase-1 and increase of its DNA binding affinity based on polymorphism of G-172->T J Biol Chem 284 20175 20183 19447888 1:CAS:528:DC%2BD1MXos1ens7c%3D 10.1074/jbc.M109.019414
108. T Ono A Muto T Kaneda E Arita T Yoshida 2009 Novel linkage disequilibrium of single nucleotide polymorphisms in the transcriptional regulatory region of mu-opioid receptor gene in Japanese population Biol Pharm Bull 32 721 723 19336912 1:CAS:528:DC%2BD1MXmsVWks78%3D 10.1248/bpb.32.721
109. G Oroszi RF Anton S O'Malley R Swift H Pettinati D Couper Q Yuan D Goldman 2009 OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach Alcohol Clin Exp Res 33 383 393 19053977 1:CAS:528:DC%2BD1MXktVyhu7Y%3D 10.1111/j.1530-0277.2008.00846.x
110. DW Oslin W Berrettini HR Kranzler H Pettinati J Gelernter JR Volpicelli CP O'Brien 2003 A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients Neuropsychopharmacology 28 1546 1552 12813472 1:CAS:528:DC%2BD3sXls1Sls78%3D 10.1038/sj.npp.1300219
111. YX Pan 2003 Identification of alternatively spliced variants from opioid receptor genes Methods Mol Med 84 65 75 12703318 1:CAS:528:DC%2BD3sXjtlaht74%3D
112. I Racz B Schurmann A Karpushova M Reuter S Cichon C Montag R Furst C Schutz PE Franke J Strohmaier TF Wienker L Terenius U Osby A Gunnar W Maier A Bilkei-Gorzo M Nothen A Zimmer 2008 The opioid peptides enkephalin and beta-endorphin in alcohol dependence Biol Psychiatry 64 989 997 18589403 1:CAS:528:DC%2BD1cXhtlCrtb3M 10.1016/j.biopsych.2008.05.008
113. VA Ramchandani J Umhau FJ Pavon V Ruiz-Velasco W Margas H Sun R Damadzic R Eskay M Schoor A Thorsell ML Schwandt WH Sommer DT George LH Parsons P Herscovitch D Hommer M Heilig 2011 A genetic determinant of the striatal dopamine response to alcohol in men Mol Psychiatry 16 809 817 20479755 1:CAS:528:DC%2BC3MXpt1ahtbk%3D 10.1038/mp.2010.56
114. LA Ray 2011 Stress-induced and cue-induced craving for alcohol in heavy drinkers: preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes Alcohol Clin Exp Res 35 166 174 21039637 10.1111/j.1530-0277.2010.01333.x
115. LA Ray KE Hutchison 2004 A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans Alcohol Clin Exp Res 28 1789 1795 15608594 1:CAS:528:DC%2BD2cXhtVylt7fL 10.1097/01.ALC.0000148114. 34000.B9
116. LA Ray KE Hutchison 2007 Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study Arch Gen Psychiatry 64 1069 1077 17768272 1:CAS:528:DC%2BD2sXhtFGgtbnK 10.1001/archpsyc.64.9.1069
117. R Ray GA Doyle JJ Crowley RJ Buono DW Oslin AA Patkar P Mannelli PA DeMaria Jr. CP O'Brien WH Berrettini 2005 A functional prodynorphin promoter polymorphism and opioid dependence Psychiatr Genet 15 295 298 16314761 10.1097/00041444-200512000-00013
118. LA Ray KE Hutchison JR Ashenhurst AL Morrow 2010 Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation Alcohol Clin Exp Res 34 1479 1487 20528823 1:CAS:528:DC%2BC3cXhtFWgsL3K
119. R Ray K Ruparel A Newberg EP Wileyto JW Loughead C Divgi JA Blendy J Logan JK Zubieta C Lerman 2011 Human mu opioid receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers Proc Natl Acad Sci USA 108 9268 9273 21576462 1:CAS:528: DC%2BC3MXnsVKhtL8%3D 10.1073/pnas.1018699108
120. MV Rockman MW Hahn N Soranzo F Zimprich DB Goldstein GA Wray 2005 Ancient and recent positive selection transformed opioid cis-regulation in humans PLoS Biol 3 e387 16274263 10.1371/journal.pbio.0030387 1:CAS:528:DC%2BD2MXhtlWls7nJ
121. H Rommelspacher M Smolka LG Schmidt J Samochowiec MR Hoehe 2001 Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals Alcohol 24 129 135 11522434 1:CAS:528:DC%2BD3MXmtV2ltb0%3D 10.1016/S0741-8329(01)00139-2
122. M Rouault DA Nielsen A Ho MJ Kreek V Yuferov 2011 Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity Addict Biol 16 334 346 20731629 10.1111/j.1369-1600.2010.00248.x
123. G Rubio G Ponce R Rodriguez-Jimenez MA Jimenez-Arriero J Hoenicka T Palomo 2005 Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone? Alcohol Alcohol 40 227 233 15797885 1:CAS:528:DC%2BD2MXjtlegu7g%3D
124. K Rutten J De Vry W Bruckmann TM Tzschentke 2011 Pharmacological blockade or genetic knockout of the NOP receptor potentiates the rewarding effect of morphine in rats Drug Alcohol Depend 114 253 256 21095077 1:CAS:528: DC%2BC3MXjs1yrtb0%3D
125. F Rutters AG Nieuwenhuizen SG Lemmens F Bouwman E Mariman MS Westerterp-Plantenga 2011 Associations between anthropometrical measurements, body composition, single-nucleotide polymorphisms of the hypothalamus/pituitary/ adrenal (HPA) axis and HPA axis functioning Clin Endocrinol (Oxf) 74 679 686 1:CAS:528:DC%2BC3MXnvFOjsLY%3D 10.1111/j.1365-2265.2011.03985.x
126. T Sander N Gscheidel B Wendel J Samochowiec M Smolka H Rommelspacher LG Schmidt MR Hoehe 1998 Human mu-opioid receptor variation and alcohol dependence Alcohol Clin Exp Res 22 2108 2110 9884158 1:CAS:528:DyaK1MXlsF2rsw%3D%3D
127. JA Schinka T Town L Abdullah FC Crawford PI Ordorica E Francis P Hughes AB Graves JA Mortimer M Mullan 2002 A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances Mol Psychiatry 7 224 228 11840318 1:CAS:528:DC%2BD38XitVSntbY%3D 10.1038/sj.mp.4000951
128. JH Schluger A Ho L Borg M Porter S Maniar M Gunduz G Perret A King MJ Kreek 1998 Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism Alcohol Clin Exp Res 22 1430 1436 9802524 1:CAS:528: DyaK1cXnt1egurc%3D 10.1111/j.1530-0277.1998.tb03931.x
129. Schwandt ML, Lindell SG, Higley JD, Suomi SJ, Heilig M, Barr CS (2011) OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques. Psychoneuroendocrinology 36:1303-1311
130. E Setiawan RO Pihl SM Cox C Gianoulakis RM Palmour C Benkelfat M Leyton 2011 The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype Alcohol Clin Exp Res 35 1134 1141 21410481 1:CAS:528: DC%2BC3MXoslOlsrY%3D 10.1111/j.1530-0277.2011.01446.x
131. SA Shabalina DV Zaykin P Gris AY Ogurtsov J Gauthier K Shibata IE Tchivileva I Belfer B Mishra C Kiselycznyk MR Wallace R Staud NA Spiridonov MB Max D Goldman RB Fillingim W Maixner L Diatchenko 2009 Expansion of the human mu-opioid receptor gene architecture: novel functional variants Hum Mol Genet 18 1037 1051 19103668 1:CAS:528:DC%2BD1MXisFSmt7s%3D 10.1093/hmg/ddn439
132. J Shi L Hui Y Xu F Wang W Huang G Hu 2002 Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin Hum Mutat 19 459 460 11933204 10.1002/humu.9026 1:CAS:528:DC%2BD38Xjs12nsbY%3D
133. RJ Smith GA Doyle AM Han JJ Crowley DW Oslin AA Patkar P Mannelli PA DeMaria Jr. CP O'Brien WH Berrettini 2005 Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence Am J Med Genet B Neuropsychiatr Genet 133B 105 109 15558714 10.1002/ajmg.b.30105
134. M Smolka T Sander LG Schmidt J Samochowiec H Rommelspacher N Gscheidel B Wendel MR Hoehe 1999 Mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal Psychoneuroendocrinology 24 629 638 10399772 1:CAS:528:DyaK1MXktFKrurk%3D 10.1016/S0306-4530(99)00017-7
135. JE Sturgess TP George JL Kennedy A Heinz DJ Muller 2011 Pharmacogenetics of alcohol, nicotine and drug addiction treatments Addict Biol 16 357 376 21362114 1:CAS:528:DC%2BC3MXpvVWqtr8%3D 10.1111/j.1369-1600.2010.00287.x
136. CY Szeto NL Tang DT Lee A Stadlin 2001 Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts NeuroReport 12 1103 1106 11338173 1:CAS:528:DC%2BD3MXjs1egurw%3D 10.1097/00001756-200105080-00011
137. EC Tan CH Tan U Karupathivan EP Yap 2003 Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations NeuroReport 14 569 572 12657887 1:CAS:528:DC%2BD3sXitlKhsrk%3D 10.1097/00001756-200303240-00008
138. MM Taqi I Bazov H Watanabe F Nyberg T Yakovleva G Bakalkin 2011 Prodynorphin promoter SNP associated with alcohol dependence forms noncanonical AP-1 binding site that may influence gene expression in human brain Brain Res 1385 18 25 21338584 1:CAS:528:DC%2BC3MXjvFWjt7Y%3D 10.1016/j.brainres.2011.02. 042
139. M Telkov T Geijer L Terenius 1998 Human prodynorphin gene generates several tissue-specific transcripts Brain Res 804 284 295 9757065 1:CAS:528:DyaK1cXmt1enur0%3D 10.1016/S0006-8993(98)00706-9
140. JW Tidey PM Monti DJ Rohsenow CJ Gwaltney R Miranda Jr. JE McGeary J MacKillop RM Swift DB Abrams S Shiffman JA Paty 2008 Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment Alcohol Clin Exp Res 32 58 66 18028530 1:CAS:528:DC%2BD1cXhvVSns70%3D 10.1111/j.1530-0277.2007.00545.x
141. T Town L Abdullah F Crawford J Schinka PI Ordorica E Francis P Hughes R Duara M Mullan 1999 Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency Am J Med Genet 88 458 461 10490697 1:STN:280:DyaK1MvitFCrsQ%3D%3D 10.1002/(SICI)1096-8628(19991015)88:5<458:: AID-AJMG3>3.0.CO;2-S
142. A Troisi G Frazzetto V Carola G Di Lorenzo M Coviello FR D'Amato A Moles A Siracusano C Gross 2011 Social hedonic capacity is associated with the A118G polymorphism of the mu-opioid receptor gene (OPRM1) in adult healthy volunteers and psychiatric patients Soc Neurosci 6 88 97 20486014 10.1080/17470919.2010. 482786
143. JT Tuusa UE Petaja-Repo 2011 Phe27Cys polymorphism of the human delta opioid receptor predisposes cells to compromised calcium signaling Mol Cell Biochem 351 173 181 21234650 1:CAS:528:DC%2BC3MXjvFejtbg%3D 10.1007/s11010-011- 0725-5
144. EJ Vallender D Ruedi-Bettschen GM Miller DM Platt 2010 A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys Drug Alcohol Depend 109 252 256 20153935 1:CAS:528:DC%2BC3cXmsVeiur0%3D 10.1016/j.drugalcdep.2010.01.005
145. MM Vanyukov RE Tarter L Kirisci GP Kirillova BS Maher DB Clark 2003 Liability to substance use disorders: 1. Common mechanisms and manifestations Neurosci Biobehav Rev 27 507 515 14599432 10.1016/j.neubiorev.2003.08.002
146. GS Wand M McCaul X Yang J Reynolds D Gotjen S Lee A Ali 2002 The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade Neuropsychopharmacology 26 106 114 11751037 1:CAS:528:DC%2BD3MXpt1antbc%3D 10.1016/S0893-133X(01)00294-9
147. D Wang JM Quillan K Winans JL Lucas W Sadee 2001 Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding J Biol Chem 276 34624 34630 11457836 1:CAS:528:DC%2BD3MXmvFClt7g%3D 10.1074/jbc.M104083200
148. JL Weber PE May 1990 Dinucleotide repeat polymorphism at the PENK locus Nucleic Acids Res 18 2200
149. SG Wei YS Zhu JH Lai HX Xue ZQ Chai SB Li 2011 Association between heroin dependence and prodynorphin gene polymorphisms Brain Res Bull 85 238 242 21382455 1:CAS:528:DC%2BC3MXntFCrtrw%3D 10.1016/j.brainresbull.2011.02.010
150. MJ Wick SR Minnerath S Roy S Ramakrishnan HH Loh 1995 Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines Brain Res Mol Brain Res 32 342 347 7500847 1:CAS:528:DyaK2MXns1Gisbc%3D 10.1016/0169-328X(95)00096-B
151. TJ Williams KS LaForge D Gordon G Bart S Kellogg J Ott MJ Kreek 2007 Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence Addict Biol 12 496 502 17559549 1:CAS:528:DC%2BD2sXhtFGgsLvF 10.1111/j.1369-1600.2007.00069.x
152. W Wittmann E Schunk I Rosskothen S Gaburro N Singewald H Herzog C Schwarzer 2009 Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone Neuropsychopharmacology 34 775 785 18800067 1:CAS:528:DC%2BD1MXkvVaksg%3D%3D 10.1038/npp.2008.142
153. Z Xie Z Li L Guo C Ye J Li X Yu H Yang Y Wang C Chen D Zhang LY Liu-Chen 2007 Regulator of G protein signaling proteins differentially modulate signaling of mu and delta opioid receptors Eur J Pharmacol 565 45 53 17433292 1:CAS:528:DC%2BD2sXlvFantrk%3D 10.1016/j.ejphar.2007.03.005
154. K Xu XH Liu S Nagarajan XY Gu D Goldman 2002 Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case/control sample Am J Med Genet 110 45 50 12116270 10.1002/ajmg.10374
155. J Xu M Xu YL Hurd GW Pasternak YX Pan 2009 Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene J Neurochem 108 962 972 19077058 1:CAS:528:DC%2BD1MXisV2ht7c%3D 10.1111/j.1471-4159.2008.05833.x
156. X Xuei D Dick L Flury-Wetherill HJ Tian A Agrawal L Bierut A Goate K Bucholz M Schuckit J Nurnberger Jr. J Tischfield S Kuperman B Porjesz H Begleiter T Foroud HJ Edenberg 2006 Association of the kappa-opioid system with alcohol dependence Mol Psychiatry 11 1016 1024 16924269 1:CAS:528: DC%2BD28XhtFWns7bI 10.1038/sj.mp.4001882
157. X Xuei L Flury-Wetherill L Bierut D Dick J Nurnberger Jr. T Foroud HJ Edenberg 2007 The opioid system in alcohol and drug dependence: family-based association study Am J Med Genet B Neuropsychiatr Genet 144 877 884
158. X Xuei L Flury-Wetherill L Almasy L Bierut J Tischfield M Schuckit JI Nurnberger Jr. T Foroud HJ Edenberg 2008 Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence Addict Biol 13 80 87 17910740 1:CAS:528: DC%2BD1cXktVaitr8%3D 10.1111/j.1369-1600.2007.00082.x
159. V Yuferov D Fussell KS LaForge DA Nielsen D Gordon A Ho SM Leal J Ott MJ Kreek 2004 Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction Pharmacogenetics 14 793 804 15608558 1:CAS:528:DC%2BD2cXhtVylt7fM 10.1097/00008571-200412000- 00002
160. V Yuferov F Ji DA Nielsen O Levran A Ho S Morgello R Shi J Ott MJ Kreek 2009 A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain Neuropsychopharmacology 34 1185 1197 18923396 1:CAS:528:DC%2BD1MXjtFentb0%3D 10.1038/npp.2008.187
161. V Yuferov O Levran D Proudnikov DA Nielsen MJ Kreek 2010 Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment Ann N Y Acad Sci 1187 184 207 20201854 1:CAS:528:DC%2BC3cXks1Smsr0%3D 10.1111/j.1749-6632.2009.05275.x
162. Y Zhang D Wang AD Johnson AC Papp W Sadee 2005 Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G J Biol Chem 280 32618 32624 16046395 1:CAS:528:DC%2BD2MXhtVWiur7I 10.1074/jbc. M504942200
163. Zhang H, Luo X, Kranzler HR, Lappalainen J, Yang BZ, Krupitsky E, Zvartau E, Gelernter J (2006) Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 15:807-819
164. D Zhang C Shao M Shao P Yan Y Wang Y Liu W Liu T Lin Y Xie Y Zhao D Lu Y Li L Jin 2007 Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population Biol Psychiatry 61 1244 1251 17157823 1:CAS:528:DC%2BD2sXls1aju70%3D 10.1016/j.biopsych.2006.07.012
165. H Zhang HR Kranzler BZ Yang X Luo J Gelernter 2008 The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk Mol Psychiatry 13 531 543 17622222 1:CAS:528: DC%2BD1cXkvVShtrk%3D 10.1038/sj.mp.4002035
166. H Zhang HR Kranzler RD Weiss X Luo KT Brady RF Anton LA Farrer J Gelernter 2009 Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies Biol Psychiatry 66 128 136 19217079 1:CAS:528:DC%2BD1MXnvVantrw%3D 10.1016/j.biopsych.2008.12.021
167. H Zhang J Gelernter JR Gruen HR Kranzler AI Herman AA Simen 2010 Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region J Hum Genet 55 278 284 20300121 1:CAS:528:DC%2BC3cXmsVSlt78%3D 10.1038/jhg.2010.22
168. A Zimprich J Kraus M Woltje P Mayer E Rauch V Hollt 2000 An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression J Neurochem 74 472 477 10646497 1:CAS:528:DC%2BD3cXntFOrsQ%3D%3D 10.1046/j.1471-4159.2000.740472.x